GYRE icon

Gyre Therapeutics
GYRE

Overview Fund Trends Analyst Outlook Journalist POV

51 hedge funds and large institutions have $13.7M invested in Gyre Therapeutics in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding in top 10

Funds holding in top 10: →

54% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 26

82% less capital invested

Capital invested by funds: $75.5M → $13.7M (-$61.8M)

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$435K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.58M
2
+$943K
3
+$469K
4
Morgan Stanley
Morgan Stanley
New York
+$399K
5
NCM
Nantahala Capital Management
Connecticut
+$301K

Top Sellers

1
-$10.8M
2
-$5.87M
3
-$4.11M
4
SCM
Sio Capital Management
New York
-$2.56M
5
ACP
Acuta Capital Partners
California
-$1.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$66K
27
$61K
28
$61K
29
$43K
30
$42K
31
$38K
32
$30K
33
$30K
34
$29K
35
$28K
36
$27K
37
$23K
38
$16K
39
$16K
40
$15K
41
$12K
42
$9K
43
$7K
44
$5K
45
$5K
46
$2K
47
$1K
48
$424
49
$197
50
–
1
2
3